MedPath

to study ovarian cancers and hormone receptor expression on them

Not Applicable
Conditions
Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
Registration Number
CTRI/2022/11/047202
Lead Sponsor
Rohilkhand Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All the cases of ovarian tumors received in department of pathology and diagnosed on histopathology in Rohilkhand medical college and hospital during the study period.

Exclusion Criteria

Non neoplastic lesions as diagnosed by histopathology

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study histopathological spectrum of ovarian tumors with emphasis on estrogen & progesterone receptor expression and their correlation with clinicopathological parameters.Timepoint: After operative procedure
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath